Children & Families
Expanding access to birth control is the surest way to defend women’s right to choose
On October 22, the Engelberg Center for Health Care Reform hosted a roundtable webinar, “Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near Real-Time: Learnings from PRISM.”
The roundtable featured presentations from key experts on lessons learned from the implementation of the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) project, a coordinated federal strategy to monitor the safety of the 2009 H1N1 influenza vaccine using observational data from large health plans. Presenters provided an overview of PRISM and project conclusions, and described technical findings related to data infrastructure and methodological approaches. Discussion also focused on plans to integrate PRISM with the Mini-Sentinel active surveillance system.
Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near-Real Time: Learnings from PRISM
Agenda
-
October 22
-
Welcome and Introduction
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University -
HHS Rapid Response to a Public Health Need: H1N1 Vaccine Safety Surveillance
DSDan Salmon National Vaccine Program Office, U.S. Department of Health and Human Services -
Data Infrastructure and Methodological Lessons Learned from PRISM
RPRichard Platt Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute -
Next Steps for Vaccine Safety Surveillance
RBRobert Ball Deputy Director of the Office of Surveillance and Epidemiology - U.S. Food and Drug Administration
-
